Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.1%

4 terminated/withdrawn out of 33 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

42%

5 of 12 completed trials have results

Key Signals

6 recruiting5 with results

Enrollment Performance

Analytics

N/A
18(62.1%)
Phase 1
4(13.8%)
Phase 2
4(13.8%)
Phase 3
2(6.9%)
Phase 4
1(3.4%)
29Total
N/A(18)
Phase 1(4)
Phase 2(4)
Phase 3(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (33)

Showing 20 of 33 trials
NCT07548164Phase 3Recruiting

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

Role: collaborator

NCT07280247Not ApplicableRecruiting

Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness

Role: lead

NCT07282002Not ApplicableNot Yet Recruiting

Percutaneous AngioVac Vegetation Extraction (PAVE) to Remove Right Heart Vegetations in Patients With Infective Endocarditis

Role: lead

NCT07472439Not ApplicableNot Yet Recruiting

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone in Europe

Role: lead

NCT06378047Phase 1Completed

Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer

Role: collaborator

NCT06777901Phase 4Recruiting

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

Role: lead

NCT01153035Not ApplicableActive Not Recruiting

Excision Followed by Radiofrequency Ablation for Breast Cancer

Role: collaborator

NCT07191548Not ApplicableNot Yet Recruiting

International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE

Role: lead

NCT07192731Not ApplicableNot Yet Recruiting

International Study on Treatment of Liver (HCC) Patients With IRE

Role: lead

NCT06697314Not ApplicableRecruiting

Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System

Role: lead

NCT06630624Phase 1Recruiting

Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

Role: collaborator

NCT03899649Active Not Recruiting

A Registry Study of NanoKnife IRE for Stage 3 Pancreatic Cancer

Role: lead

NCT03899636Phase 3Active Not Recruiting

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

Role: lead

NCT04972097Not ApplicableCompleted

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue

Role: lead

NCT05284240Not ApplicableCompleted

Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries

Role: collaborator

NCT06185556Phase 2Recruiting

COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases

Role: collaborator

NCT05318092Not ApplicableCompleted

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

Role: lead

NCT04510714Not ApplicableUnknown

BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation]

Role: collaborator

NCT04229563Unknown

Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease

Role: lead

NCT01972867Not ApplicableUnknown

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

Role: lead